Beam Therapeutics Inc. announced the pricing of an underwritten offering of approximately 16.15 million shares of common stock at $28.48 each, alongside pre-funded warrants for nearly 1.4 million ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results